MedTrace Logo

SSP-002358 Drug Interaction Study With Omeprazole

NCT01415349 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2021-06-10

Study results available
· View outcomes & findings →

Summary

This is a drug interaction study evaluating whether blood plasma concentrations of SSP-002358-base are altered when SSP-002358 is taken together with omeprazole.

Conditions

  • Healthy

Interventions

DRUG

SSP-002358

1 mg, oral, once

DRUG

SSP-002358 + omeprazole

SSP-002358 (1 mg) + omeprazole (40 mg) given orally, once

Sponsors & Collaborators

  • Shire

    lead INDUSTRY

Principal Investigators

  • Study Director · Takeda

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-11
Primary Completion
2011-09-28
Completion
2011-09-28

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01415349 on ClinicalTrials.gov